Literature DB >> 24955233

Metal-catalyzed uncaging of DNA-binding agents in living cells.

Mateo I Sánchez1, Cristina Penas1, M Eugenio Vázquez1, José L Mascareñas1.   

Abstract

Attachment of alloc protecting groups to the amidine units of fluorogenic DNA-binding bisbenzamidines or to the amino groups of ethidium bromide leads to a significant reduction of their DNA affinity. More importantly, the active DNA-binding species can be readily regenerated by treatment with ruthenium catalysts in aqueous conditions, even in cell cultures. The catalytic chemical uncaging can be easily monitored by fluorescence microscopy, because the protected products display both different emission properties and cell distribution to the parent compounds.

Entities:  

Year:  2014        PMID: 24955233      PMCID: PMC4064253     

Source DB:  PubMed          Journal:  Chem Sci        ISSN: 2041-6520            Impact factor:   9.825


  43 in total

Review 1.  From transcription factors to designed sequence-specific DNA-binding peptides.

Authors:  M Eugenio Vázquez; Ana M Caamaño; J L Mascareñas
Journal:  Chem Soc Rev       Date:  2003-11       Impact factor: 54.564

2.  A photoswitchable DNA-binding protein based on a truncated GCN4-photoactive yellow protein chimera.

Authors:  Stacy-Anne Morgan; G Andrew Woolley
Journal:  Photochem Photobiol Sci       Date:  2010-09-13       Impact factor: 3.982

Review 3.  Prodrugs: design and clinical applications.

Authors:  Jarkko Rautio; Hanna Kumpulainen; Tycho Heimbach; Reza Oliyai; Dooman Oh; Tomi Järvinen; Jouko Savolainen
Journal:  Nat Rev Drug Discov       Date:  2008-03       Impact factor: 84.694

4.  Photoswitched DNA-binding of a photochromic spiropyran.

Authors:  Johanna Andersson; Shiming Li; Per Lincoln; Joakim Andréasson
Journal:  J Am Chem Soc       Date:  2008-08-13       Impact factor: 15.419

5.  Stimuli-responsive selection of target DNA sequences by synthetic bZIP peptides.

Authors:  Jesús Mosquera; Adrián Jiménez-Balsa; Verónica I Dodero; M Eugenio Vázquez; José L Mascareñas
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 6.  Drug--DNA interactions.

Authors:  J B Chaires
Journal:  Curr Opin Struct Biol       Date:  1998-06       Impact factor: 6.809

Review 7.  Synthetic DNA minor groove-binding drugs.

Authors:  B S Reddy; S M Sondhi; J W Lown
Journal:  Pharmacol Ther       Date:  1999-10       Impact factor: 12.310

8.  Photocontrollable sequence-specific DNA alkylation by a pyrrole-imidazole polyamide seco-CBI conjugate.

Authors:  Soyoung Park; Toshikazu Bando; Ken-Ichi Shinohara; Shigeki Nishijima; Hiroshi Sugiyama
Journal:  Bioconjug Chem       Date:  2010-12-30       Impact factor: 4.774

9.  Light-controlled DNA binding of bisbenzamidines.

Authors:  Mateo I Sánchez; Olalla Vázquez; M Eugenio Vázquez; José L Mascareñas
Journal:  Chem Commun (Camb)       Date:  2011-09-12       Impact factor: 6.222

10.  Synthesis, photophysical properties, and nucleic acid binding of phenanthridinium derivatives based on ethidium.

Authors:  Nathan W Luedtke; Qi Liu; Yitzhak Tor
Journal:  Bioorg Med Chem       Date:  2003-11-17       Impact factor: 3.641

View more
  3 in total

Review 1.  Organometallic catalysis in aqueous and biological environments: harnessing the power of metal carbenes.

Authors:  Sara Gutiérrez; María Tomás-Gamasa; José Luis Mascareñas
Journal:  Chem Sci       Date:  2022-05-16       Impact factor: 9.969

2.  Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.

Authors:  Jason T Weiss; John C Dawson; Craig Fraser; Witold Rybski; Carmen Torres-Sánchez; Mark Bradley; E Elizabeth Patton; Neil O Carragher; Asier Unciti-Broceta
Journal:  J Med Chem       Date:  2014-06-12       Impact factor: 7.446

3.  A cell-penetrating artificial metalloenzyme regulates a gene switch in a designer mammalian cell.

Authors:  Yasunori Okamoto; Ryosuke Kojima; Fabian Schwizer; Eline Bartolami; Tillmann Heinisch; Stefan Matile; Martin Fussenegger; Thomas R Ward
Journal:  Nat Commun       Date:  2018-05-16       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.